In vivo effect of granulocyte-macrophage colony-stimulating factor and interferon combination on monocyte-macrophage and T-lymphocyte functions in chronic hepatitis B leukocytopenic patients
J. Kountouras et al., In vivo effect of granulocyte-macrophage colony-stimulating factor and interferon combination on monocyte-macrophage and T-lymphocyte functions in chronic hepatitis B leukocytopenic patients, HEP-GASTRO, 45(24), 1998, pp. 2295-2302
BACKGROUND/AIMS: Both rhGM-CSF and IFN-gamma have antiviral and immunoregul
atory effects. Furthermore, GM-CSF has the advantage of increasing WBC in l
eukocytopenic patients.
METHODOLOGY: We investigated a) the antiviral effects of rhGM-CSF and INF-a
lpha combination treatment in 12 chronic hepatitis B patients with leukocyt
openia as a result or not of previous interferon therapy, b) the in, vivo e
ffects of these agents on monocyte-macrophage and T-lymphocyte functions an
d, c) their correlation to HBV infection outcome.
RESULTS: Combination therapy caused a significant fall in HBV-DNA levels (p
<0.0002), accompanied by significant reductions in transaminase levels and
in histological activity index (p<0.0001, in each case). In parallel, rhGM-
CSF induced a 2.7- to 5-fold weekly increment in WBC. Moreover, treatment c
aused a significant increase in all monocyte-macrophage parameters (p<0.000
1 for random, directed migration and phagocytosis index) and in peripheral
blood lymphocyte parameters (p<0.0001 for IL-2r and HLA-DR expression) stud
ied. A similar picture was also obtained from cytokine levels (IL-2 and GM-
CSF) in the supernatants from PHA-cultured T-lymphocytes (p<0.0003,<0.001,
respectively).
CONCLUSIONS: The combined therapy achieves the initial treatment aim of inc
reasing WBC and exerting an antiviral effect. In addition, the observed cha
nges in immunological parameters probably reflect a Th1 pattern of immune r
esponse that could be responsible for the fate of HBV infection. Finally, c
ytokine levels (IL-2 and GM-CSF) in the supernatants might serve to monitor
viral activity and outcome of the HBV infection.